Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Eosinophilic Asthma Market Report 2025

Eosinophilic Asthma Global Market Report 2025 - By Disease (Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma), By Treatment (Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments), By End User (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Eosinophilic Asthma Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Eosinophilic Asthma Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Eosinophilic Asthma Market

Eosinophilic asthma is a form of asthma where high eosinophil counts, a specific white blood cell type, cause airway inflammation. This condition results in severe symptoms such as breathing issues and recurring flare-ups, with limited effectiveness from standard treatments such as inhaled steroids.

The main diseases types in the eosinophilic asthma are severe eosinophilic asthma and mild to moderate eosinophilic asthma. Severe eosinophilic asthma is a severe variant of asthma marked by elevated levels of eosinophils, a type of white blood cell that plays a role in airway inflammation. Treatment options include biologics, bronchodilators, corticosteroids, Immunomodulators, and other therapies. These treatments are used in hospitals, clinics, and other healthcare settings.

How Is The Eosinophilic Asthma Market Segmented?

The eosinophilic asthma market covered in this report is segmented –

1) By Disease: Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma

2) By Treatment: Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma

2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma

Eosinophilic Asthma Market Size and growth rate 2025 to 2029: Graph

What Is The Eosinophilic Asthma Market Size 2025 And Growth Rate?

The eosinophilic asthma market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to increase in pollution, lower immunity in population, rise in prevalence of eosinophilic asthma, increase in prevalence of allergens and respiratory conditions, rise in healthcare expenditure, and rise in R&D activities.

What Is The Eosinophilic Asthma Market Growth Forecast?

The eosinophilic asthma market size is expected to see rapid growth in the next few years. It will grow to $6.01 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising awareness and diagnosis rates, expanding therapeutic indications for monoclonal antibodies, growing investment in healthcare infrastructure, and the rising personalized medicine approaches. Major trends in the forecast period include development of targeted biologics, improved diagnostic tools, personalized treatment approaches, enhanced drug delivery systems, integration of digital health technologies, and expanded clinical trials for novel therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Eosinophilic Asthma Market: Impact Of Rising Smoking Habits On The Growth Of The Market

The rising smoking habits is expected to propel the growth of the eosinophilic asthma market going forward. Smoking habits refer to the regular behaviors or patterns of using tobacco products, such as the frequency, context, and duration of smoking, often influenced by psychological, social, and environmental factors. The rising smoking habits are due to factors such as increased stress levels, targeted marketing by tobacco companies, lack of awareness about health risks, and social acceptance of smoking in certain cultures. Eosinophilic asthma treatment helps reduce airway inflammation and improve lung function, which can encourage smoking cessation by alleviating the respiratory issues that often drive patients to continue smoking. For instance, in December 2023, according to the National Health Service, a UK-based government department, there were an estimated 408,700 hospital admissions due to smoking in 2022–23 from 389,800 in 2021–22, representing an increase of 4.8%. Therefore, the rising smoking rates drives the eosinophilic asthma market.

Who Are The Major Players In The Global Eosinophilic Asthma Market?

Major companies operating in the eosinophilic asthma market are Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A.

What Are The Key Trends Of The Global Eosinophilic Asthma Market: Advancements In Targeted Therapies For Severe Asthma Management

Major companies operating in the eosinophilic asthma market are developing innovative drugs, to target specific immune pathways, reduce inflammation, and improve patient outcomes through personalized treatment options. A monoclonal antibody is a type of laboratory-made molecule that can mimic the immune system's ability to fight off harmful pathogens such as viruses and bacteria that are created through a process involving the fusion of a specific antibody-producing cell with a cancer cell, allowing the production of large quantities of identical antibodies. For instance, in August 2024, AstraZeneca plc, a UK-based biopharmaceutical company announced Fasenra approved by the China's National Medical Products Association, a China-based government agency for the treatment of severe eosinophilic asthma. It is specifically indicated for patients with severe eosinophilic asthma, a condition characterized by high levels of eosinophils, which can lead to inflammation and worsening asthma symptoms. It is a monoclonal antibody that targets and depletes eosinophils through a unique mechanism. Fasenra enhances the immune system's ability by binding to the IL-5 receptor on eosinophils, to reduce eosinophil levels in the blood and tissues. The dosing regimen involves an initial loading phase followed by maintenance doses. Patients usually receive injections every four weeks for the first three doses, followed by every eight weeks thereafter.

What Are Latest Mergers And Acquisitions In The Eosinophilic Asthma Market: Strategic Acquisition Enhances Respiratory Portfolio And Expands Patient Reach

In February 2024, GSK plc, a UK-based biopharmaceutical company, acquired Aiolos Bio for $1 billion. With this acquisition, GSK aims to boost its respiratory portfolio by targeting severe asthma patients with low T2 inflammation and expand its market reach and leadership in respiratory therapies while addressing a broader spectrum of asthma patients. Aiolos Bio is a US based biotechnology company specializes in developing treatments for respiratory and inflammatory conditions including eosinophilic asthma.

What Is The Regional Outlook For The Global Eosinophilic Asthma Market?

North America was the largest region in the eosinophilic asthma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eosinophilic asthma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the eosinophilic asthma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Eosinophilic Asthma  Market?

The eosinophilic asthma market consists of sales of mepolizuma and benralizumab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Eosinophilic Asthma  Industry?

The eosinophilic asthma market research report is one of a series of new reports from The Business Research Company that provides eosinophilic asthma market statistics, including the eosinophilic asthma industry's global market size, regional shares, competitors with an eosinophilic asthma market share, detailed eosinophilic asthma market segments, market trends and opportunities, and any further data you may need to thrive in the eosinophilic asthma industry. This eosinophilic asthma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Eosinophilic Asthma Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $3.17 billion
Revenue Forecast In 2034 $6.01 billion
Growth Rate CAGR of 17.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The eosinophilic asthma market covered in this report is segmented –
1) By Disease: Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma
2) By Treatment: Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments
3) By End User: Hospitals, Clinics, Other End Users Subsegments:
1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma
2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Eosinophilic Asthma Market Characteristics

    3. Eosinophilic Asthma Market Trends And Strategies

    4. Eosinophilic Asthma Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Eosinophilic Asthma Growth Analysis And Strategic Analysis Framework

    5.1. Global Eosinophilic Asthma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Eosinophilic Asthma Market Growth Rate Analysis

    5.4. Global Eosinophilic Asthma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Eosinophilic Asthma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Eosinophilic Asthma Total Addressable Market (TAM)

    6. Eosinophilic Asthma Market Segmentation

    6.1. Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Severe Eoisnophilic Asthma

    Mild To Moderate Eosinophilic Asthma

    6.2. Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Biologics

    Bronchodilators

    Corticosteroids

    Immunomodulators

    Other Treatments

    6.3. Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Other End Users

    6.4. Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Refractory Eosinophilic Asthma

    Late-Onset Eosinophilic Asthma

    6.5. Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Early-Onset Eosinophilic Asthma

    Intermittent Eosinophilic Asthma

    7. Eosinophilic Asthma Market Regional And Country Analysis

    7.1. Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Eosinophilic Asthma Market

    8.1. Asia-Pacific Eosinophilic Asthma Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Eosinophilic Asthma Market

    9.1. China Eosinophilic Asthma Market Overview

    9.2. China Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Eosinophilic Asthma Market

    10.1. India Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Eosinophilic Asthma Market

    11.1. Japan Eosinophilic Asthma Market Overview

    11.2. Japan Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Eosinophilic Asthma Market

    12.1. Australia Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Eosinophilic Asthma Market

    13.1. Indonesia Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Eosinophilic Asthma Market

    14.1. South Korea Eosinophilic Asthma Market Overview

    14.2. South Korea Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Eosinophilic Asthma Market

    15.1. Western Europe Eosinophilic Asthma Market Overview

    15.2. Western Europe Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Eosinophilic Asthma Market

    16.1. UK Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Eosinophilic Asthma Market

    17.1. Germany Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Eosinophilic Asthma Market

    18.1. France Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Eosinophilic Asthma Market

    19.1. Italy Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Eosinophilic Asthma Market

    20.1. Spain Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Eosinophilic Asthma Market

    21.1. Eastern Europe Eosinophilic Asthma Market Overview

    21.2. Eastern Europe Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Eosinophilic Asthma Market

    22.1. Russia Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Eosinophilic Asthma Market

    23.1. North America Eosinophilic Asthma Market Overview

    23.2. North America Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Eosinophilic Asthma Market

    24.1. USA Eosinophilic Asthma Market Overview

    24.2. USA Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Eosinophilic Asthma Market

    25.1. Canada Eosinophilic Asthma Market Overview

    25.2. Canada Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Eosinophilic Asthma Market

    26.1. South America Eosinophilic Asthma Market Overview

    26.2. South America Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Eosinophilic Asthma Market

    27.1. Brazil Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Eosinophilic Asthma Market

    28.1. Middle East Eosinophilic Asthma Market Overview

    28.2. Middle East Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Eosinophilic Asthma Market

    29.1. Africa Eosinophilic Asthma Market Overview

    29.2. Africa Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Eosinophilic Asthma Market Competitive Landscape And Company Profiles

    30.1. Eosinophilic Asthma Market Competitive Landscape

    30.2. Eosinophilic Asthma Market Company Profiles

    30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    31. Eosinophilic Asthma Market Other Major And Innovative Companies

    31.1. GSK plc

    31.2. Amgen Inc.

    31.3. Viatris Inc.

    31.4. Teva Pharmaceutical Industries Limited

    31.5. Boehringer Ingelheim GmbH

    31.6. Regeneron Pharmaceuticals Inc.

    31.7. Chiesi Farmaceutici S.p.A.

    31.8. Company 13

    31.9. Company 14

    31.10. Company 15

    31.11. Company 16

    31.12. Company 17

    31.13. Company 18

    31.14. Company 19

    31.15. Company 20

    32. Global Eosinophilic Asthma Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Eosinophilic Asthma Market

    34. Recent Developments In The Eosinophilic Asthma Market

    35. Eosinophilic Asthma Market High Potential Countries, Segments and Strategies

    35.1 Eosinophilic Asthma Market In 2029 - Countries Offering Most New Opportunities

    35.2 Eosinophilic Asthma Market In 2029 - Segments Offering Most New Opportunities

    35.3 Eosinophilic Asthma Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Roche Holding AG Financial Performance
  • Table 77: Sanofi S.A. Financial Performance
  • Table 78: Bristol-Myers Squibb Company Financial Performance
  • Table 79: AstraZeneca plc Financial Performance
  • Table 80: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Roche Holding AG Financial Performance
  • Figure 77: Sanofi S.A. Financial Performance
  • Figure 78: Bristol-Myers Squibb Company Financial Performance
  • Figure 79: AstraZeneca plc Financial Performance
  • Figure 80: Novartis AG Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

Read More

What Is The Healthcare IT Consulting Market Overview In 2022?

Read More

How Will The Stem Cell Assay Market Grow In 2022?

Read More

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

Anti-Asthmatics And COPD Drugs Global Market Report 2025 – By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (Hospital Pharmacies, General Pharmacies, Online Retailers), By End User (Asthma Patients, COPD Patients), By Therapy (Preventive, Curative), By Route Of Administration (Oral, Inhaled, Intravenous, Subcutaneous), By Age Group (Below 5, 5-14, 15-60, Above 60) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Asthma Drugs Global Market Report 2025 – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma), By Therapy (Preventive, Curative), By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End-User (Asthma Patients, COPD Patients) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Treatment Global Market Report 2025 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immune Health Supplements Global Market Report 2025 – By Ingredients Type( Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form( Soft Gels Or Capsules, Tablets, Powder, Liquid, Other Forms), By Source Type( Plant-Based, Animal-Based), By Distribution Channel( Pharmacies and Drug Stores, Hypermarket or Supermarket, Online Stores, Specialty Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2025 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer, Other Applications), By End-Users  (Hospitals, Specialty Clinics, Academic and Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lower Respiratory Tract Therapeutics Global Market Report 2025 – By Disease Type (Asthma, Chronic obstructive pulmonary disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases), By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drug, Cough Suppressant, Nasal Decongestant, Other Drug Classes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2025 – By Drug (Palivizumab, Ribavirin, Other Drugs), By Treatment (Immune Prophylaxis, Supportive Care, Antiviral Medications), By Dosage Form (Oral, Injectable, Other Dosage Forms), By Patient Type (Pediatrics, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Eosinophilic Asthma market?

Eosinophilic asthma is a form of asthma where high eosinophil counts, a specific white blood cell type, cause airway inflammation. This condition results in severe symptoms such as breathing issues and recurring flare-ups, with limited effectiveness from standard treatments such as inhaled steroids. For further insights on the Eosinophilic Asthma market, request a sample here

How will the Eosinophilic Asthma market drivers and restraints affect the market dynamics? What forces will shape the Eosinophilic Asthma industry going forward?

The Eosinophilic Asthma market major growth driver - Impact Of Rising Smoking Habits On The Growth Of The Market. For further insights on the Eosinophilic Asthma market, request a sample here

What is the forecast market size or the forecast market value of the Eosinophilic Asthma market?

The Eosinophilic Asthma market size has grown strongly in recent years. The eosinophilic asthma market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to increase in pollution, lower immunity in population, rise in prevalence of eosinophilic asthma, increase in prevalence of allergens and respiratory conditions, rise in healthcare expenditure, and rise in R&D activities. The eosinophilic asthma market size is expected to see rapid growth in the next few years. It will grow to $6.01 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising awareness and diagnosis rates, expanding therapeutic indications for monoclonal antibodies, growing investment in healthcare infrastructure, and the rising personalized medicine approaches. Major trends in the forecast period include development of targeted biologics, improved diagnostic tools, personalized treatment approaches, enhanced drug delivery systems, integration of digital health technologies, and expanded clinical trials for novel therapies. For further insights on the Eosinophilic Asthma market, request a sample here

How is the Eosinophilic Asthma market segmented?

The eosinophilic asthma market covered in this report is segmented –
1) By Disease: Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma
2) By Treatment: Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments
3) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma
2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma For further insights on the Eosinophilic Asthma market, request a sample here

Which region has the largest share of the Eosinophilic Asthma market? What are the other regions covered in the report?

North America was the largest region in the eosinophilic asthma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eosinophilic asthma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Eosinophilic Asthma market, request a sample here.

Who are the major players in the Eosinophilic Asthma market?

Major companies operating in the eosinophilic asthma market are Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A. . For further insights on the Eosinophilic Asthma market, request a sample here.

What are the key trends in the Eosinophilic Asthma market?

Major trends in the Eosinophilic Asthma market include Advancements In Targeted Therapies For Severe Asthma Management. For further insights on the Eosinophilic Asthma market, request a sample here.

What are the major opportunities in the Eosinophilic Asthma market? What are the strategies for the Eosinophilic Asthma market?

For detailed insights on the major opportunities and strategies in the Eosinophilic Asthma market, request a sample here.

How does the Eosinophilic Asthma market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Eosinophilic Asthma market growth and SWOT analysis of the Eosinophilic Asthma industry, request a sample here.

For detailed insights on Eosinophilic Asthma's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Eosinophilic Asthma industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Eosinophilic Asthma industry,

What are the key dynamics influencing the Eosinophilic Asthma market growth? SWOT analysis of the Eosinophilic Asthma market. request a sample here.